are compound pharmacies still making tirzepatide Update: On December 19th the FDA ruled the tirzepatide shortage was resolved, however is giving a grace period for compounding to continuing manufacturing. This grace period is 60 days. On Compounded Zepbound alternatives disappear :

Liraglutide : Once opened, these can remain unrefrigerated for 30 days, as long as temperatures stay below 86F (30C)

Standard deal structures in pharma licensing typically feature upfront payments in the range of USD 25-250 million (depending on stage), development milestones totaling USD 200-1,500 million contingent on Phase III and NDA events, and royalty rates of 8-20% on net sales depending on the stage at licensing, the strategic value to the licensee, and the therapeutic area

Additional analyses may include assessment of peptide stability under varying storage conditions, structural integrity following reconstitution, mapping of interaction patterns within IGF-associated pathways, and observation of downstream intracellular signaling responses within regulated in vitro and preclinical experimental systems

No, starting at the maintenance dose of 2.4 mg is not recommended